New York S 1316: Directs the health care quality and cost containment commission to study and report upon the impact of requiring that certain health insurance plans provide coverage for treatment of mitochondrial disease

Status: REFERRED TO INSURANCE (as of 2018-01-03)

State: New York · Session: 2017-2018 · Bill: S 1316

Sponsors: LITTLE, KENNEDY, MARCHIONE, ORTT

View New York S 1316 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.